Generic name: Capmatinib tablets
Brand name: Capanib
Composition:
Each tablet contains:
Capmatinib…………………200mg
Indications:
Used for the treatment of adult patients with metastatic, non-small cell lung cancer (NSCLC) whose tumors have tested positive for a mutation that leads to MET exon 14 skipping.
Dosage:
• Take 2 tablets (400mg) twice daily, every 12 hours at scheduled times. If patient misses or vomits a dose, do not make up dose but take the next dose at its scheduled time.
• Continue until disease progression or unacceptable toxicity.
Contraindications:
• None reported.
Warnings:
• Do not take if pregnant, perform pregnancy test prior to initiating dosage, use contraception while medicating and for 1 week after last dose.
• Do not take while breastfeeding.
• If patient develops interstitial lung disease/pneumonitis of any degree immediately and permanently discontinue.
Adverse Effects:
• Bloating or swelling of the face, arms, hands, lower legs or feet.
• Chest pain, decreased or loss of appetite, difficult or labored breathing, general feeling of discomfort or illness, itching, nausea and vomiting.
Dosage form: Reddish brown tablets.
Expiry date: 24months after date of manufacture.
Packaging:
• 56 tablets per bottle.
Storage:
• Store in the original packaging.
• Store under 25°C protected from moisture.
• Keep out of reach of children.
DISCLAIMER
The information on this website about our medications is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
For your safety:
Do not self-diagnose or treat any medical condition based solely on the information on this website. If you have any questions or concerns about a medication, please talk to your doctor or pharmacist.
